USD 0.67
(-7.25%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 24.59 Million USD | 29.89% |
2022 | 18.93 Million USD | 90052.38% |
2021 | 21 Thousand USD | -90.54% |
2020 | 222 Thousand USD | -51.21% |
2019 | 455 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 23.44 Million USD | -4.36% |
2024 Q1 | 24.5 Million USD | -0.34% |
2023 Q4 | 24.59 Million USD | -17.49% |
2023 FY | 24.59 Million USD | 29.89% |
2023 Q1 | 17.49 Million USD | -7.59% |
2023 Q3 | 29.8 Million USD | -0.58% |
2023 Q2 | 29.97 Million USD | 71.35% |
2022 Q2 | 23.11 Million USD | 48052.08% |
2022 Q3 | 24.86 Million USD | 7.57% |
2022 Q4 | 18.93 Million USD | -23.85% |
2022 FY | 18.93 Million USD | 90052.38% |
2022 Q1 | 48 Thousand USD | 128.57% |
2021 Q3 | 66 Thousand USD | -47.2% |
2021 Q1 | 178 Thousand USD | -19.82% |
2021 Q4 | 21 Thousand USD | -68.18% |
2021 Q2 | 125 Thousand USD | -29.78% |
2021 FY | 21 Thousand USD | -90.54% |
2020 FY | 222 Thousand USD | -51.21% |
2020 Q1 | 378 Thousand USD | -16.92% |
2020 Q2 | 319 Thousand USD | -15.61% |
2020 Q3 | 258 Thousand USD | -19.12% |
2020 Q4 | 222 Thousand USD | -13.95% |
2019 Q2 | 509 Thousand USD | -7.45% |
2019 FY | 455 Thousand USD | 0.0% |
2019 Q3 | 477 Thousand USD | -6.29% |
2019 Q4 | 455 Thousand USD | -4.61% |
2019 Q1 | 550 Thousand USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aspira Women's Health Inc. | 1.43 Million USD | -1619.65% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -2098.632% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -30138.306% |
Standard BioTools Inc. | 3.98 Million USD | -517.399% |
Inotiv, Inc. | 399.4 Million USD | 93.843% |
Prenetics Global Limited | 867.21 Thousand USD | -2735.629% |
Neuronetics, Inc. | 59.28 Million USD | 58.519% |
Star Equity Holdings, Inc. | 1.14 Million USD | -2047.686% |
Castle Biosciences, Inc. | 14.19 Million USD | -73.2% |
Psychemedics Corporation | 945 Thousand USD | -2502.222% |
RadNet, Inc. | 812.06 Million USD | 96.972% |
Exact Sciences Corporation | 2.47 Billion USD | 99.007% |
IDEXX Laboratories, Inc. | 622.88 Million USD | 96.052% |
iSpecimen Inc. | 29.13 Thousand USD | -84318.126% |
OpGen, Inc. | 2.02 Million USD | -1116.403% |
Exagen Inc. | 19.23 Million USD | -27.872% |
Bionano Genomics, Inc. | 7.17 Million USD | -242.732% |
CareDx, Inc | 28.27 Million USD | 13.038% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 79.17 Million USD | 68.94% |
Guardant Health, Inc. | 1.13 Billion USD | 97.843% |
Biodesix, Inc. | 35.22 Million USD | 30.189% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -24799.001% |
Precipio, Inc. | 106 Thousand USD | -23099.057% |
Natera, Inc. | 282.94 Million USD | 91.309% |
Fulgent Genetics, Inc. | 10.11 Million USD | -143.21% |
Sera Prognostics, Inc. | 840 Thousand USD | -2827.5% |
23andMe Holding Co. | 67.84 Million USD | 63.754% |
OPKO Health, Inc. | 222.03 Million USD | 88.925% |
Personalis, Inc. | 1.23 Million USD | -1892.788% |
Aclaris Therapeutics, Inc. | 3.07 Million USD | -699.967% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -3226.876% |
T2 Biosystems, Inc. | 6.59 Million USD | -272.704% |
Neogen Corporation | 888.39 Million USD | 97.232% |
Myriad Genetics, Inc. | 130.9 Million USD | 81.214% |
ICON Public Limited Company | 3.66 Billion USD | 99.329% |
NeoGenomics, Inc. | 606.06 Million USD | 95.943% |
Star Equity Holdings, Inc. | 1.14 Million USD | -2047.686% |
MDxHealth SA | 35.56 Million USD | 30.854% |
Prenetics Global Limited | 867.21 Thousand USD | -2735.629% |
Illumina, Inc. | 1.48 Billion USD | 98.348% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -12703.678% |
Medpace Holdings, Inc. | 142.12 Million USD | 82.697% |
Mainz Biomed B.V. | 2.19 Million USD | -1019.865% |
Trinity Biotech plc | 54.65 Million USD | 55.004% |
Sotera Health Company | 2.22 Billion USD | 98.894% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -2098.632% |